Acne

As 2025 comes to a close, Dermatology Times is taking a look back at the studies, therapies, and advances in acne this year.

In part 3 of this supplement, experts discuss treatment options for adults with hormonal pattern acne and PIH.

In part 2 of this supplement, experts discuss therapies for inflammatory acne

In part 1 of this supplement, experts discuss current and emerging treatments for patients, considering lifestyle choices.

A bentonite and Alcea sulphurea facial mask significantly improved acne severity and patient satisfaction in a recent clinical trial.

However, over half of the patients reported experiencing psychological symptoms such as mood changes and depression during treatment.

Mondana Ghias, MD, FAAD, offers strategies for dermatologists in managing skin reactions from lung cancer treatments to enhance patient care and quality of life.

While individual fatty acids in tallow have known biological effects, their combined impact in whole tallow remains uncertain.

This review of the latest dermatologic studies highlights new research on acne, including post-treatment recurrence, the use of AI, severity in cystic fibrosis patients, and more.

Denifanstat emerges as a groundbreaking oral therapy for acne, targeting sebum production and inflammation, promising safer, effective treatment options.

Baldwin discusses the latest advancements in acne and rosacea treatments, including innovative therapies and promising clinical trials.

From acne to psoriasis, nutrition influences disease severity, treatment response, and patient quality of life.

Explore innovative acne management strategies from James Del Rosso, DO, focusing on personalized treatments and patient education for effective results in diverse cases.

Indomo's ClearPen could revolutionize acne treatment with at-home microneedle injections, offering instant access to effective corticosteroid therapy for inflammatory lesions.

FDA warns of serious risks associated with RF microneedling, urging patient education and careful provider training to ensure safety in aesthetic dermatology.

Through 3 complex cases, participants explored practical ways to integrate agents like clascoterone and tazarotene into daily practice.

Topical dapsone shows promise in treating various mucocutaneous diseases, including rosacea and neutrophilic dermatoses, with a favorable safety profile.

New research highlights the link between isotretinoin dosage and increased chronic hand eczema, emphasizing the need for careful monitoring during acne treatment.

A poster at Maui Derm NP+PA Fall shows trifarotene cream's promise in treating acne and post-inflammatory hyperpigmentation in diverse patients, enhancing skin health and appearance.

Denifanstat shows promising results in treating moderate to severe acne vulgaris, achieving significant efficacy and safety at the EADV Congress 2025.

Isotretinoin significantly reduces inflammatory cytokines IL-8, IL-36, and TWEAK in acne patients, promoting long-term acne remission and healing.

Biofrontera Inc. advances acne treatment with aminolevulinic acid hydrochloride gel, completing a phase 2b study for moderate to severe cases.

Joshua Zeichner, MD, spoke to Dermatology Times about Sanofi's clinical trials for the world’s first mRNA acne vaccine, aiming to revolutionize treatment by targeting the body’s inflammatory response rather than just symptoms.

The latest study reveals the link between cosmetic use and acne, highlighting the risks of comedogenic ingredients in moisturizers, facial cleansers, and powders.

Explore innovative acne therapies, including bimekizumab, offering hope for treatment-resistant acne conglobata and improved patient outcomes.